| Product Code: ETC9202314 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Antithrombotic Drugs Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Antithrombotic Drugs Market - Industry Life Cycle |
3.4 Serbia Antithrombotic Drugs Market - Porter's Five Forces |
3.5 Serbia Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Serbia Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Serbia Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Serbia Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Serbia Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Serbia Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Serbia Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Serbia |
4.2.2 Growth in geriatric population leading to higher demand for antithrombotic drugs |
4.2.3 Rising awareness about the importance of anticoagulant therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of antithrombotic drugs |
4.3.2 High cost associated with antithrombotic medications |
4.3.3 Limited access to healthcare facilities in certain regions of Serbia |
5 Serbia Antithrombotic Drugs Market Trends |
6 Serbia Antithrombotic Drugs Market, By Types |
6.1 Serbia Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Serbia Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 Serbia Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 Serbia Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 Serbia Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 Serbia Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 Serbia Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 Serbia Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Serbia Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 Serbia Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 Serbia Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 Serbia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Serbia Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Serbia Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 Serbia Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Serbia Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 Serbia Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 Serbia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Serbia Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Serbia Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Serbia Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Serbia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Serbia Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Serbia Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Serbia Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Serbia Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Serbia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Serbia Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Serbia Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Serbia Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Serbia Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Serbia Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Serbia Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 Serbia Antithrombotic Drugs Market Export to Major Countries |
7.2 Serbia Antithrombotic Drugs Market Imports from Major Countries |
8 Serbia Antithrombotic Drugs Market Key Performance Indicators |
8.1 Average prescription rate of antithrombotic drugs per capita |
8.2 Number of healthcare providers offering antithrombotic treatments |
8.3 Patient adherence rate to antithrombotic drug therapy |
9 Serbia Antithrombotic Drugs Market - Opportunity Assessment |
9.1 Serbia Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Serbia Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Serbia Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Serbia Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Serbia Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Serbia Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Serbia Antithrombotic Drugs Market - Competitive Landscape |
10.1 Serbia Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Serbia Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here